Status:
COMPLETED
RCT of Russian IDU Peer Network HIV Prevention Intervention - 1
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Johns Hopkins University
Conditions:
HIV Infections
Eligibility:
All Genders
16-100 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to conduct a randomized controlled trial to assess the efficacy of a peer-educator intervention focused on injection drug users and their drug and sexual networks. We expe...
Detailed Description
Intravenous drug use (IDU) is driving the HIV epidemic in Russia; over 90% of all HIV-1 infections have occurred within communities of IDUs. In St. Petersburg (population 5 million), the prevalence of...
Eligibility Criteria
Inclusion
- Of legal age to independently provide written informed consent for research
- Report having injected drugs at least 12 times in the last three months
- HIV seronegative (ELISA confirmed)
- Willing and able to recruit at least three HIV risk network members who are eligible for study participation
Exclusion
- Prior or concurrent enrollment in the last 6 months in another HIV behavioral or biomedical prevention study
- Psychological disturbance or cognitive impairment that appears to limit the ability to understand study procedures, as determined by clinic staff
- Any other condition that, in the opinion of the investigator, would make participation in the study unsafe, or otherwise interfere with the study objectives
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00218673
Start Date
October 1 2003
End Date
June 1 2009
Last Update
May 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biomedical Center
Saint Petersburg, Russia, 197110